Walleye Capital’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.93M Buy
+200,419
New +$6.06M 0.02% 641
2024
Q3
Sell
-48,768
Closed -$917K 5740
2024
Q2
$917K Sell
48,768
-48,414
-50% -$985K ﹤0.01% 2934
2024
Q1
$2.25M Buy
97,182
+19,312
+25% +$513K ﹤0.01% 1927
2023
Q4
$2.18M Sell
77,870
-3,147
-4% -$63.7K ﹤0.01% 1712
2023
Q3
$1.69M Buy
81,017
+10,691
+15% +$197K ﹤0.01% 1861
2023
Q2
$1.1M Sell
70,326
-39,619
-36% -$383K ﹤0.01% 1774
2023
Q1
$860K Sell
109,945
-41,384
-27% -$364K 0.01% 1285
2022
Q4
$1.7M Buy
+151,329
New +$796K 0.03% 671

Other funds holding PHVS

Walleye Capital's PHVS Position: Q2 2026 in Review

Walleye Capital opened a new position in Pharvaris (PHVS) in Q2 2026: 200,419 shares worth $6.93M. The stake represents 0.02% of the portfolio and ranks #641 among its holdings. This is a return to the name: Walleye Capital previously reported a position in PHVS as recently as Q2 2024.

Walleye Capital first reported a position in PHVS in Q4 2022 and has held it in 8 quarters since. 23 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Walleye Capital held 200,419 shares of Pharvaris worth $6.93M as of Q2 2026.
  • Pharvaris was a new Walleye Capital position in Q2 2026.
  • Pharvaris made up 0.02% of Walleye Capital's portfolio in Q2 2026, its #641 holding.
  • Walleye Capital first reported a position in Pharvaris in Q4 2022 and has held it in 8 quarters since.
  • 23 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.